| Treating benign prostate hyperplasia with SARMS JT Dalton, DD Miller, MS Steiner, KA Veverka, W Gao US Patent 7,776,921, 2010 | 28 | 2010 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent 7,767,661, 2010 | 19 | 2010 |
| Treating benign prostate hyperplasia with SARMS JT Dalton, DD Miller, MS Steiner, KA Veverka, W Gao US Patent 8,088,828, 2012 | 17 | 2012 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent App. 11/139,200, 2005 | 17 | 2005 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent 8,592,488, 2013 | 8 | 2013 |
| Protopanaxadiol-type ginsenoside compositions and uses thereof TE Daley, M Tempesta US Patent 8,440,632, 2013 | 7 | 2013 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent 8,729,136, 2014 | 5 | 2014 |
| 2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer RW Brueggemeier, YW Kim US Patent 7,105,542, 2006 | 3 | 2006 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent 9,126,913, 2015 | 2 | 2015 |
| Process for the production of compositions containing ribonucleotides and their use as flavouring agents B Noordam, JG Kortes US Patent 8,084,068, 2011 | 2 | 2011 |
| 2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer RW Brueggemeier, YW Kim US Patent 7,829,557, 2010 | 2 | 2010 |
| The process of preparing the topical anti-inflammatory/analgesic preparation BM Khamar, VD Mody, KK Pandya | 2 | 2002 |
| Micro-emulsions for the treatment of rheumatic disorders M Chaudhary, V Naithani US Patent 9,345,660, 2016 | 1 | 2016 |
| Could BTCBAM Become a Strong Alternative to BITCOIN? EA Arkan, G Gursoy, E Darlan, S Yorulmaz, G Alkan, EC Alkoclar Hacking Life, 2021 | | 2021 |
| A Pro-Somathropic Formulation with GH and T3 mRNA Expression Enhancement Properties EC Alkoclar Collective Wisdom, 2020 | | 2020 |
| Diarylalkanes as potent inhibitors of binuclear enzymes Q Jia, JF Zhao US Patent 10,548,825, 2020 | | 2020 |
| 15-antiviral eng. docx MEC Alkoclar, MM Yesil | | 2019 |
| 31-sinir buyume eng. docx MEC Alkoclar, MM Yesil | | 2018 |
| A Novel Approach for The Treatment of Inflammation : Dual Suppression of FMO3 and Nf-Kappa B EC Alkoclar EP Patent TR201,304,603, 2013 | | 2013 |
| An Immunomodulative Formulation with Allergic Reaction Inhibitive Properties EC Alkoclar Works in Progress, 0 | | |
